Proposal to award sole supply and change some anti-retroviral brands


16 October 2018 - PHARMAC is seeking feedback on a proposal to make several changes to funding of anti-retroviral therapies used in the treatment of HIV infection.

  • Award sole supply and change brands for three anti-retrovirals
  • Award sole supply and maintain existing brands for four anti-retrovirals

Brand changes would have a transition period of three months, starting 1 April 2019 and would include reference pricing. New pricing would be confirmed if PHARMAC decides to implement the proposed changes.

Read PHARMAC consultation

Michael Wonder

Posted by:

Michael Wonder